Global Patient Monitoring Devices Market Set for Robust Growth, Reaches USD 125.2 Million by 2032

Future Market Insights (FMI) has released a groundbreaking market study revealing substantial growth in the global patient monitoring devices market. Achieving a notable valuation of USD 46.4 million in 2022, the market is poised for remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 10.5% from 2022 to 2032. FMI anticipates the market will surge to an estimated USD 125.2 million by 2032.

The healthcare sector’s increasing focus on continuous monitoring and proactive management of patient health is driving the demand for advanced patient monitoring devices. These devices are essential in facilitating real-time data collection and enhancing patient outcomes through timely intervention and management.

Key Growth Drivers and Innovations:

The FMI report highlights that Blood Glucose Monitoring Systems are expected to lead the market growth, boasting a forecasted CAGR of approximately 12.2% during the forecast period. This growth is attributed to the rising emphasis on proactive health management and the need for precise, real-time monitoring to ensure optimal patient care.

Recent advancements in technology have significantly transformed the patient monitoring devices industry. These innovations have reshaped healthcare practices by enabling continuous tracking of vital physiological parameters such as heart rate, blood pressure, respiratory rate, and temperature. The integration of real-time data and instant alerts empowers healthcare providers to promptly detect changes in a patient’s condition, facilitating timely and effective interventions.

Industry Dynamics and Future Outlook:

Several factors contribute to the robust growth of the patient monitoring devices market, including technological advancements, heightened awareness of preventive healthcare, and the increasing prevalence of chronic diseases. As a result, there is a growing demand for innovative and efficient monitoring solutions.

Stakeholders across the industry, including manufacturers, healthcare providers, and investors, are closely monitoring these developments and opportunities. FMI’s comprehensive report provides invaluable insights for strategic planning and informed decision-making in this dynamic market.

The projected growth of the patient monitoring devices industry underscores its critical role in advancing healthcare. With ongoing technological advancements, these devices are expected to become even more integral to enhancing patient care and improving the overall efficiency of healthcare systems worldwide.

Key Takeaways: Patient Monitoring Devices Market

• The global patient monitoring devices market is experiencing significant growth, reaching a valuation of USD 46.4 million in 2022.
• The market is expected to expand at a CAGR of 10.5% from 2022 to 2032, reaching USD 125.2 million by 2032.
• The US holds the largest market share, projected to reach USD 48 billion by 2032 with a CAGR of 11.1%.
• The UK and Japan markets are also anticipated to grow substantially, reaching USD 5.5 million and USD 4.7 billion respectively by 2032.

Discover the Full Insights: Find the Complete Patient Monitoring Devices Market Report

Competitive Analysis:

• Honeywell,
• American Telecare,
• Roche,
• Philips Healthcare,
• Intel,
• Welch Allyn,
• Health anywhere Inc.,
• Johnson & Johnson,
• Bosch,
• Biotronik,
• Covidien Plc

Some of the recent developments of Patient Monitoring Devices Market key providers are as follows:

• In October 2021, Honeywell unveiled the Real-Time Health Monitoring System (RTHMS), integrating advanced hardware with data analytics software to enhance real-time and remote patient monitoring. This system also aims to digitize and automate critical and time-consuming tasks for medical staff, potentially reducing administrative workload by 35%.
• In June 2020, Abbott received FDA approval for the FreeStyle Libre 2 Integrated Continuous Glucose Monitoring (iCGM) device. This innovative device measures glucose levels every minute and features real-time alarms. Its self-applied iCGM sensor eliminates the need for finger pricks, with Bluetooth technology providing automatic alerts for any significant changes in blood glucose levels.
• In January 2020, Medtronic obtained FDA clearance for the Micra AV, recognized as the smallest pacemaker designed for atrioventricular synchronization.

Segments Covered in Patient monitoring devices industry Analysis:

By Product Type:

• Blood Glucose Monitoring Systems
  • Self-monitoring Blood Glucose Systems
  • Continuous Glucose Monitoring Systems
• Cardiac Monitoring Devices
  • ECG Devices
  • Implantable Loop Recorders
  • Event Monitors
  • Mobile Cardiac Telemetry Monitors
  • Smart/Wearable ECG Monitors
• Multi-parameter Monitoring Devices
  • Low-acuity Monitoring Devices
  • Mid-acuity Monitoring Devices
  • High-acuity Monitoring Devices
  • Overall
  • Pulse Oximeters
  • Spirometers
  • Capnography
  • Peak Flow Meters
• Temperature Monitoring Devices
  • Handheld Temperature Monitoring Devices
  • Table-top Temperature Monitoring Devices
  • Wearable Continuous Monitoring Devices
  • Invasive Temperature Monitoring Devices
  • Smart Temperature Monitoring Devices

By End User:

• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Other End-user

By Region:

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube